As of 31 Dec 2025, 15 institutional investors reported holding 108,913 shares of Sonoma Pharmaceuticals, Inc. - COM (SNOA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 108,913 | $396,443 | +$180,029 | $3.64 | 15 |
| 2025 Q3 | 59,360 | $230,316 | -$45,711 | $3.88 | 19 |
| 2025 Q2 | 84,902 | $241,989 | +$156,743 | $2.84 | 13 |
| 2025 Q1 | 33,057 | $71,462 | +$27,365 | $2.19 | 12 |
| 2024 Q4 | 20,132 | $54,155 | -$24,564 | $2.69 | 8 |
| 2024 Q3 | 27,765 | $85,239 | +$84,891 | $3.07 | 12 |
| 2024 Q2 | 5 | $1 | +$1 | $0.20 | 1 |